NASDAQ:LYEL | P/S Ratio | Lyell Immunopharma, Inc.

Historical market capitalization divided by trailing-four-quarter filed revenue.

Available history
2021-06-30 to 2026-09-03
Data captured

Historical P/S Ratio

DateP/S Ratio
2026-09-0313,033.1
2026-06-3012,175.01
2026-03-3115,095.73
2025-12-3118,169.91
2025-09-307,642.29
2025-06-302,185.08
2025-03-3148,880.8
2024-12-313,093.78
2024-09-30112,399.33
2024-06-30137,453.73
2024-03-31167,202.03
2023-12-3175,796.61
2023-09-30152.67
2023-06-30329.31
2023-03-31139.93
2022-12-31204.53
2022-09-30934.04
2022-06-30769.58
2022-03-312,830.29
2021-12-313,528.25
2021-09-306,999.76
2021-06-309,163.89